Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05862649 · ClinicalTrials.gov registry record · NA

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by NeuraLight.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
5
Study locations

NCT05862649 is a NA study of Parkinson Disease that is actively recruiting participants, run by NeuraLight. The registered enrollment target is 300 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05862649, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by NeuraLight.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
5
Study locations

Study Summary

This is a multicenter longitudinal study in about 300 patients with Idiopathic Parkinson's disease, who will be evaluated in several clinical centers with a clinical assessment and an oculometric examination during a time period with specific intervals. This study aims to evaluate the correlation between oculometric measures and clinical assessment over time, as well as the potential to detect early change in clinical status using an oculometric assessment.

Conditions Studied

Interventions

  • OTHER NeuraLight

Study Locations (5)

Other

  • AIBILI research center - Coimbra
  • Instituto de Biomedicina de Sevilla (IBiS) - Seville
  • University Hospital Zürich - Zurich
  • The VCTC - Oxford

Illinois

  • Rush University - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-08-21
Est. Completion 2025-11-15
Phase NA

Sponsor

NeuraLight

2 total trials

What the Registry Record Tells You About NCT05862649

The ClinicalTrials.gov registry entry for NCT05862649 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (94% lower). The listed sponsor is NeuraLight, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which NeuraLight is the first listed.

NCT05862649 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Other, Illinois.

Frequently Asked Questions

What is clinical trial NCT05862649 about?

NCT05862649 is a clinical study titled "Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease". This is a multicenter longitudinal study in about 300 patients with Idiopathic Parkinson's disease, who will be evaluated in several clinical centers with a clinical assessment and an oculometric examination during a time period with specific intervals. This study aims to evaluate the correlation be...

What is the current status of trial NCT05862649?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-08-21. Estimated completion is 2025-11-15.

What conditions does trial NCT05862649 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05862649?

The interventions under investigation include: NeuraLight (OTHER).

Who is sponsoring clinical trial NCT05862649?

This trial is sponsored by NeuraLight, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05862649 being conducted?

This trial has 5 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.